<?xml version="1.0" encoding="UTF-8"?>
<ref id="B97">
 <label>97.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kibuuka</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Berkowitz</surname>
    <given-names>NM</given-names>
   </name>
   <name>
    <surname>Millard</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Enama</surname>
    <given-names>ME</given-names>
   </name>
   <name>
    <surname>Tindikahwa</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Sekiziyivu</surname>
    <given-names>AB</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial</article-title>. 
  <source>Lancet</source> (
  <year>2015</year>) 
  <volume>385</volume>:
  <fpage>1545</fpage>â€“
  <lpage>54</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(14)62385-0</pub-id>
  <?supplied-pmid 25540891?>
  <pub-id pub-id-type="pmid">25540891</pub-id>
 </mixed-citation>
</ref>
